Article metrics

Download PDFPDF

TP007/#1383  A phase II study of induction PD-1 blockade (nivolumab) in patients with surgically completely resectable mismatch repair deficient endometrial cancer (NIVEC)
Free

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2024

AbstractFullPdf
Nov 202385021
Dec 202355011
Jan 20242903
Feb 20243202
Mar 202432011
Apr 20242001
May 20242003
Jun 2024803
Total281055